Citeal (ciprofloxacin) solution for external use 250 ml.

Description

Ciprofloxacin is indicated for the treatment of the following infections (see the sections “application Features” and “Pharmacological properties”). Before starting therapy, special attention should be paid to all available information regarding resistance to ciprofloxacin. Official recommendations for the proper use of antibacterial drugs should be taken into account.

Adults

Lower respiratory tract infections caused by gram-negative bacteria: – exacerbation of chronic obstructive pulmonary disease;
bronchopulmonary infections in cystic fibrosis or bronchiectasis;
pneumonia.
Chronic purulent otitis media of the middle ear.
Exacerbation of chronic sinusitis, especially if it is caused by gram-negative bacteria.
Urinary tract infections.
Gonococcal urethritis and cervicitis.
Orhoepididimit, in particular caused by Neisseria gonorrhoeae.
Inflammatory diseases of the pelvic organs, in particular caused by Neisseria gonorrhoeae.
For the above-mentioned infections of the genital tract, when Neisseria gonorrhoeae is known or suspected as a pathogen, it is especially important to obtain local information about resistance to ciprofloxacin and confirm the sensitivity based on laboratory tests.

Gastrointestinal infections (for example, travelers ‘ diarrhea).
Intra-abdominal infection.
Skin and soft tissue infections caused by gram-negative bacteria.
Severe external otitis of the ear.
Infections of bones and joints.
Treatment of infections in patients with neutropenia.
Prevention of infections in patients with neutropenia.
Prevention of invasive infections caused by Neisseria meningitidis.
Pulmonary form of anthrax (prevention after contact and radical treatment).
Children

Bronchopulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa.
Complicated urinary tract infections and pyelonephritis.
Pulmonary form of anthrax (prevention after contact and radical treatment).
Ciprofloxacin can also be used to treat severe infections in children when the doctor deems it necessary. Treatment should only be started by a doctor who has experience in treating cystic fibrosis and / or severe infections in children (see the sections “application Features” and “Pharmacological properties”).